Central and Peripheral Sensitization, and Pain Contributing Factors in Shoulder Pain Patients and Healthy People

NCT05360589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2024-02-14

No results posted yet for this study

Summary

Compared to healthy subjects, central and peripheral sensitization will be investigated in patients with non-specific shoulder pain, since no data is available at the moment. The Central Sensitization Inventory (CSI) will be administered to assess sensitization in patients and controls, and changes in the mechanosensitivity of the upper limb will be assessed by checking for mechanical allodynia, hyperalgesia, and wind-up related to peripheral sensitization. Chronic pain mediators factors such as anxiety, depression, catastrophization, self-efficacy, and kinesiophobia will be investigated through validated rating scales. The Vagus Nerve neurodynamic test (VN-NDT) will be performed to assess any HR variability reduction related to stress mechanisms typical of chronic pain conditions. Finally, to health status of participants, following the biopsychosocial model, the Generic Core Set of the International Classification of the Functioning of Disability and Health (ICF) will be assessed.

Conditions

  • Shoulder Pain

Sponsors & Collaborators

  • Centro Medico Albese

    collaborator UNKNOWN
  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Giacomo Carta, MSc, PT BSc · University of Turin, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2022-12-30
Completion
2023-03-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360589 on ClinicalTrials.gov